Andrew J. Fromkin's most recent trade in Immunovant Inc was a trade of 210,468 Common Stock done at an average price of $33.6 . Disclosure was reported to the exchange on May 28, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Andrew J. Fromkin | Director | Sale of securities on an exchange or to another person at price $ 33.56 per share. | 28 May 2026 | 210,468 | 74,382 (0%) | 0% | 33.6 | 7,063,306 | Common Stock |
| Immunovant Inc | Andrew J. Fromkin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2026 | 77,181 | 0 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Andrew J. Fromkin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.43 per share. | 28 May 2026 | 77,181 | 280,073 (0%) | 0% | 8.4 | 650,636 | Common Stock |
| Immunovant Inc | Andrew J. Fromkin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2026 | 71,492 | 0 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Andrew J. Fromkin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.94 per share. | 28 May 2026 | 71,492 | 202,892 (0%) | 0% | 7.9 | 567,646 | Common Stock |
| Immunovant Inc | Andrew J. Fromkin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2026 | 31,668 | 0 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Andrew J. Fromkin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.99 per share. | 28 May 2026 | 31,668 | 131,400 (0%) | 0% | 5.0 | 158,023 | Common Stock |
| Immunovant Inc | Andrew J. Fromkin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.70 per share. | 28 May 2026 | 16,260 | 296,333 (0%) | 0% | 14.7 | 239,022 | Common Stock |
| Immunovant Inc | Andrew J. Fromkin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2026 | 16,260 | 0 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Andrew J. Fromkin | Director | Sale of securities on an exchange or to another person at price $ 32.64 per share. | 28 May 2026 | 11,483 | 284,850 (0%) | 0% | 32.6 | 374,805 | Common Stock |
| Immunovant Inc | Andrew J. Fromkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2026 | 13,880 | 99,732 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Andrew J. Fromkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2026 | 7,061 | 7,061 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Andrew J. Fromkin | Director | Sale of securities on an exchange or to another person at price $ 23.14 per share. | 01 Dec 2025 | 19,351 | 88,750 (0%) | 0% | 23.1 | 447,782 | Common Stock |
| Immunovant Inc | Andrew J. Fromkin | Director | Sale of securities on an exchange or to another person at price $ 23.95 per share. | 01 Dec 2025 | 2,898 | 85,852 (0%) | 0% | 23.9 | 69,407 | Common Stock |
| Immunovant Inc | Andrew J. Fromkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 16,188 | 108,101 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Andrew J. Fromkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 7,600 | 7,600 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Andrew J. Fromkin | Director | Sale of securities on an exchange or to another person at price $ 19.52 per share. | 07 Mar 2025 | 6,616 | 93,297 (0%) | 0% | 19.5 | 129,144 | Common Stock |
| Immunovant Inc | Andrew J. Fromkin | Director | Sale of securities on an exchange or to another person at price $ 19.96 per share. | 07 Mar 2025 | 1,384 | 91,913 (0%) | 0% | 20.0 | 27,625 | Common Stock |
| Immunovant Inc | Andrew J. Fromkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 11,255 | 99,913 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Andrew J. Fromkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 4,690 | 4,690 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Andrew J. Fromkin | Director | Sale of securities on an exchange or to another person at price $ 40.46 per share. | 01 Dec 2023 | 4,773 | 88,658 (0%) | 0% | 40.5 | 193,116 | Common Stock |
| Immunovant Inc | Fromkin J. Andrew | Director | Sale of securities on an exchange or to another person at price $ 38.78 per share. | 01 Dec 2023 | 3,941 | 97,067 (0%) | 0% | 38.8 | 152,832 | Common Stock |
| Immunovant Inc | Fromkin J. Andrew | Director | Sale of securities on an exchange or to another person at price $ 39.81 per share. | 01 Dec 2023 | 3,636 | 93,431 (0%) | 0% | 39.8 | 144,749 | Common Stock |
| Immunovant Inc | Andrew J. Fromkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 16,260 | 16,260 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Andrew J. Fromkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 12,523 | 101,008 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Andrew J. Fromkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 31,668 | 31,668 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Andrew J. Fromkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 21,059 | 88,485 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Andrew J. Fromkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 71,492 | 208,973 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Andrew J. Fromkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 21,726 | 67,426 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Andrew J. Fromkin | Director | Purchase of securities on an exchange or from another person at price $ 7.90 per share. | 10 Aug 2021 | 5,500 | 45,700 (0%) | 0% | 7.9 | 43,450 | Common Stock |